Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Department of Veterans Affairs |
---|---|
Information provided by: | Department of Veterans Affairs |
ClinicalTrials.gov Identifier: | NCT00105664 |
Data from VA-funded studies and the broader literature indicate that chronic stable angina (CSA) is prevalent, under recognized, under treated and associated with reduced quality of life. There are substantial opportunities for improving care of patients with this debilitating and potentially fatal problem. Because primary care providers manage most patients with CSA, efforts to improve care must necessarily involve the primary care delivery system. C3P is composed of a set of interventions employing a Collaborative Care Team model, which has been shown to be effective in managing other chronic illnesses in the primary care setting.
Condition | Intervention |
---|---|
Myocardial Ischemia Angina Pectoris Coronary Disease |
Procedure: Collaborative care model Procedure: Group interventions Procedure: Facilitated consultation |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study |
Official Title: | Collaborative Cardiac Care Project (C3P) |
Enrollment: | 287 |
Study Start Date: | October 2004 |
Study Completion Date: | July 2007 |
Arms | Assigned Interventions |
---|---|
1 | Procedure: Collaborative care model Procedure: Group interventions Procedure: Facilitated consultation |
Objectives of the proposed project are to: 1) ascertain whether a collaborative approach to managing CSA in primary care results in better symptom control and quality of life than routine care; 2) assess whether the practice of providers assigned to the intervention group is more consistent with national clinical practice guidelines than that of control providers; 3) assess satisfaction of both patients and providers with this approach to management; and 4) assess marginal cost-effectiveness.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Providers:
Patients
Exclusion Criteria:
Providers:
- No participating patients
Patients:
United States, California | |
VA Palo Alto Health Care System HSR&D COE | |
Palo Alto, California, United States, 94304-1207 | |
United States, Colorado | |
Denver VA Medical Center | |
Denver, Colorado, United States, 80220-0166 | |
United States, Oregon | |
Portland VA Medical Center | |
Portland, Oregon, United States, 97239 | |
United States, Washington | |
VA Puget Sound Health Care System | |
Seattle, Washington, United States, 98101 |
Principal Investigator: | Stephan D. Fihn, MD MPH | VA Puget Sound Health Care System, Seattle |
Responsible Party: | Department of Veterans Affairs ( Fihn, Stephan - Principal Investigator ) |
Study ID Numbers: | IHI 02-062 |
Study First Received: | March 16, 2005 |
Last Updated: | October 31, 2008 |
ClinicalTrials.gov Identifier: | NCT00105664 |
Health Authority: | United States: Federal Government |
Outcomes Assessment Primary Health Care Group Process |
Arterial Occlusive Diseases Coronary Disease Signs and Symptoms Heart Diseases Myocardial Ischemia Vascular Diseases |
Angina Pectoris Pain Arteriosclerosis Ischemia Coronary Artery Disease Chest Pain |
Pathologic Processes Cardiovascular Diseases |